Pay in 4 interest-free payments of $7.02 Learn more
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15
This requires frequent contact between the patient and the clinician
Research has demonstrated sustained growth hormone release following administration: Enhanced binding affinity to GHRH receptors compared to native GHRH Increased resistance to dipeptidyl peptidase-IV enzymatic degradation Sustained elevation of plasma growth hormone concentrations for several hours post-administration Dose-dependent increases in both growth hormone and IGF-1 levels Studies have shown that CJC-1295 increases plasma growth hormone levels by 2- to 10-fold for up to 6 days, with IGF-1 levels remaining elevated for 9-11 days following a single dose in human subjects
Kodra, J
Differentiation between these two conditions is essential because the treatments are very different
US$ 20.28
US$ 21.43
US$ 29.91
US$ 20.46
